Skip to the page

Data / Drug companies / Winder Laboratories LLC

Winder Laboratories LLC: 31 products in the FDA NDC directory, labeler code 75826

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Winder Laboratories LLC (labeler code 75826) lists 31 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 31 prescription drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on January 1, 2024.

The request: Watch Winder Laboratories LLC (FDA labeler code 75826): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
75826
Products in commercial distribution
31
Packages
57
Finished drugs by generic name
7
Prescription products
31
Over the counter products
0
Controlled substance products
Schedule II 10, Schedule IV 12, Schedule V 1
Flagged as original packager
31 of 31 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
3
Earliest marketing start
November 23, 2015
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Other unapproved drugs1961.3%
Generic drugs (ANDA)1238.7%

Products by type

TypeProductsShare
Prescription drugs31100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet1961.3%
Tablet, chewable619.4%
Solution39.7%
Elixir26.5%
Capsule13.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Fluoride75826-165Tablet, chewableOther unapproved drugsJanuary 1, 2024
Fluoride75826-164Tablet, chewableOther unapproved drugsJanuary 1, 2024
Fluoride75826-163Tablet, chewableOther unapproved drugsJanuary 1, 2024
Multivitamin with Fluoride75826-171Tablet, chewableOther unapproved drugsDecember 1, 2023
Multivitamin with Fluoride75826-170Tablet, chewableOther unapproved drugsDecember 1, 2023
Multivitamin with Fluoride75826-169Tablet, chewableOther unapproved drugsDecember 1, 2023
Diphenoxylate Hydrochloride and Atropine Sulfate75826-107TabletGeneric drugs (ANDA)April 30, 2022
Dextroamphetamine Sulfate75826-126TabletGeneric drugs (ANDA)December 6, 2021
Dextroamphetamine Sulfate75826-125TabletGeneric drugs (ANDA)December 6, 2021
Dextroamphetamine Sulfate75826-124TabletGeneric drugs (ANDA)December 6, 2021
Dextroamphetamine Sulfate75826-123TabletGeneric drugs (ANDA)December 6, 2021
Dextroamphetamine Sulfate75826-122TabletGeneric drugs (ANDA)December 6, 2021
Dextroamphetamine Sulfate75826-121TabletGeneric drugs (ANDA)December 6, 2021
Dextroamphetamine Sulfate75826-120TabletGeneric drugs (ANDA)December 6, 2021
Chlordiazepoxide Hydrochloride and Clidinium Bromide75826-134CapsuleGeneric drugs (ANDA)December 7, 2020
Phenobarbital75826-142TabletOther unapproved drugsJune 11, 2019
Phenobarbital75826-141TabletOther unapproved drugsJune 11, 2019
Phenobarbital75826-139TabletOther unapproved drugsJune 11, 2019
Phenobarbital75826-137TabletOther unapproved drugsJune 11, 2019
Morphine Sulfate75826-131SolutionGeneric drugs (ANDA)May 15, 2019
Morphine Sulfate75826-130SolutionGeneric drugs (ANDA)May 15, 2019
Morphine Sulfate75826-129SolutionGeneric drugs (ANDA)May 15, 2019
Phenobarbital75826-143TabletOther unapproved drugsOctober 1, 2018
Phenobarbital75826-140TabletOther unapproved drugsOctober 1, 2018
Phenobarbital75826-138TabletOther unapproved drugsOctober 1, 2018

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.